Barbara Zdziarska

Cladribine, But Not Fludarabine, Added to Daunorubicin and Cytarabine During Induction Prolongs Survival of Patients With Acute Myeloid Leukemia: A Multicenter, Randomized Phase III Study

Jerzy Hołowiecki, Sebastian Grosicki, Sebastian Giebel et al. · Journal of Clinical Oncology · 2012 · 258 citations · Full text

Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial.

Tadeusz Robak, Marek Kasznicki, Maria Błasińska-Morawiec et al. · PubMed · 2000 · 221 citations

Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study

Sebastian Grosicki, Tadeusz Robak, Sławomira Kyrcz‐Krzemień et al. · Leukemia · 2004 · 125 citations · Full text

Hematological Malignancy, Medicine, Acute Myeloid Leukemia +8

2‐Chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7‐year experience in Poland

Tadeusz Robak, Maria Błasińska-Morawiec, J. Błasiński et al. · European Journal Of Haematology · 1999 · 82 citations

Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial

Tadeusz Robak, Krzysztof Jamroziak, Joanna Góra‐Tybor et al. · Blood · 2007 · 75 citations · Full text